Greg Bullington

Greg Bullington is the Chief Executive Officer and Co-Founder of Magnolia Medical Technologies, where he has played a pivotal role in the company's development since its inception. He is also a member of the Board of Directors. His leadership encompasses various aspects such as clinical trial design, product portfolio development, and establishing new standards for sepsis testing accuracy. Under his guidance, Magnolia Medical has raised over $125 million to foster growth in the innovative ISDD® market, which he helped create.1

Bullington has extensive experience in the healthcare sector, having worked on product commercialization and strategy across multiple industries, including biotech and healthcare insurance. His career began at Deloitte & Touche LLP, followed by a management consulting role at Lake Partners. In 2006, he founded Forum Ventures, a consultancy aimed at accelerating growth for early to mid-stage companies.1

In addition to his corporate responsibilities, Bullington is actively involved in mentoring and philanthropy. He serves on the board of Wunderground Coffee and is a founding member of the Kyle Charvat Foundation, which supports young adults facing life-threatening cancer. He is also a member of YPO and has been recognized as a finalist for Ernst & Young’s Entrepreneur of the Year program in 2023.1

His intellectual property expertise is notable; he holds over 100 issued patents and has more than 50 pending patent applications globally.1